← All Sintx Technologies, INC filings

Sintx Technologies, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
SINT
Sintx Technologies, INC
10-K: SINTX Technologies 2025 10-K: Strategic Shift to Biomedical, Revenue Declines
SINTX Technologies reports a significant revenue decline in 2025 due to a strategic shift away from low-margin OEM contracts towards proprietary silicon nitride biomedical devices, while securing FDA clearance for a new foot and ankle system.
NASDAQ
SINT
Sintx Technologies, INC
10-K: SINTX Technologies Reports Fiscal Year 2024 Results, Focuses on Biomedical Applications
SINTX Technologies reports a net loss for fiscal year 2024 while strategically shifting focus towards biomedical applications and streamlining operations.
NASDAQ
SINT
Sintx Technologies, INC
10-K: SINTX Technologies 10-K Filing: Focus on Advanced Ceramics and Anti-Takeover Measures
SINTX Technologies' 10-K filing details its business in advanced ceramics, including biomedical, technical, and antipathogenic applications, while also outlining measures to prevent hostile takeovers.